AngioDynamics, Inc.
ANGO · NASDAQ
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Revenue | $292 | $304 | $339 | $316 |
| % Growth | -3.8% | -10.3% | 7.1% | – |
| Cost of Goods Sold | $135 | $149 | $165 | $150 |
| Gross Profit | $158 | $155 | $174 | $166 |
| % Margin | 53.9% | 50.9% | 51.4% | 52.4% |
| R&D Expenses | $26 | $32 | $30 | $31 |
| G&A Expenses | $42 | $41 | $40 | $38 |
| SG&A Expenses | $145 | $144 | $144 | $134 |
| Sales & Mktg Exp. | $103 | $103 | $104 | $95 |
| Other Operating Expenses | $26 | $172 | $51 | $30 |
| Operating Expenses | $198 | $347 | $225 | $194 |
| Operating Income | -$40 | -$192 | -$51 | -$28 |
| % Margin | -13.7% | -63.3% | -15.1% | -9% |
| Other Income/Exp. Net | $6 | $1 | -$3 | -$1 |
| Pre-Tax Income | -$34 | -$192 | -$54 | -$30 |
| Tax Expense | -$0 | -$7 | -$2 | -$3 |
| Net Income | -$34 | -$184 | -$52 | -$27 |
| % Margin | -11.6% | -60.7% | -15.5% | -8.4% |
| EPS | -0.83 | -4.59 | -1.33 | -0.68 |
| % Growth | 81.9% | -245.1% | -95.6% | – |
| EPS Diluted | -0.83 | -4.59 | -1.33 | -0.68 |
| Weighted Avg Shares Out | 41 | 40 | 39 | 39 |
| Weighted Avg Shares Out Dil | 41 | 40 | 39 | 39 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $2 | $0 | $0 |
| Interest Expense | $0 | $0 | $3 | $1 |
| Depreciation & Amortization | $26 | $28 | $31 | $29 |
| EBITDA | $2 | -$6 | $12 | $11 |
| % Margin | 0.6% | -2% | 3.6% | 3.5% |